HOLLISTON, Mass., Oct. 30, 2019 -- Biostage, Inc. (BSTG), a bioengineering company developing next-generation esophageal implants, today announced it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for the Company's le...